| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |